z-logo
open-access-imgOpen Access
Campylobacter fetus prosthetic valve endocarditis presenting as a stroke
Author(s) -
Christina Petridou,
Lenka Straková,
Ruan Simpson
Publication year - 2018
Publication title -
jmm case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 5
ISSN - 2053-3721
DOI - 10.1099/jmmcr.0.005147
Subject(s) - medicine , endocarditis , campylobacter fetus , transesophageal echocardiogram , atrial fibrillation , surgery , stroke (engine) , cardiology , fetus , pregnancy , mechanical engineering , biology , engineering , genetics
Campylobacter is a common pathogen of the gastrointestinal tract, but invasive disease is rare. Campylobacter fetus can play a role in osteomyelitis, meningitis and joint infection and has a prediliction for the vascular endothelium, causing mycotic aneurysms, thrombophlebitis and endocarditis. Here we present a case of prosthetic valve endocarditis caused by C. fetus and a review of the literature. Case presentation An 85-year-old woman with a tissue aortic valve replacement and atrial fibrillation was admitted to hospital with tonic-clonic seizures, right-sided hemiparesis, facial droop and hemianopia. Multiple cerebral emboli were seen on magnetic resonance imaging of the brain. Blood cultures grew C. fetus and an echocardiogram showed thickening and restricted movement of the aortic valve, a significant difference from an echocardiogram done 2 months before when the same organism was again isolated in blood cultures. She improved after treatment with 6 weeks of amoxicillin and 2 weeks of synergistic gentamicin for prosthetic valve endocarditis. Conclusion There have only been five previously reported cases of C. fetus prosthetic valve endocarditis and this is the only patient who presented as a stroke. The majority of surviving patients required replacement of the affected valve with only one other patient surviving in the absence of surgery. No guidelines exist on the optimum treatment of C. fetus endocarditis and this case reports adds to the growing literature on the appropriate management for this rare and potentially devastating disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom